The UK National Screening Committee (UKNSC) is consulting on its guidance covering the development, production and review of information to support all UK population screening programmes.
Today we’ve published our latest easy read information leaflet to help ensure screening is accessible to individuals with learning disabilities and low literacy levels.
We’ve updated our antenatal and newborn screening information for public and professionals following a change to the vaccination schedule for babies.
Back in November 2016 and March 2017 we published blog articles about the additional option of non-invasive prenatal testing (NIPT) to the fetal anomaly screening pathway.
What do Apple, Google, Microsoft, Facebook and Coca Cola have in common? Apparently they’re the 5 most valuable brands of 2017. So it’s likely that you’ll see their adverts, products and logos pretty much everywhere you look.
On 1 April 2017, e-learning for the NHS Screening Programmes moved to e-Learning for Healthcare (e-LfH). This move, which was a big job, involved us asking you to complete any modules remaining on the old website and signing up for e-LfH.
Personal informed choice is one of the most important principles in screening. People can decide whether or not to have screening based on the information we provide and their own attitudes and values.
It's really important that NHS services listen to the people who actually use them - patients and members of the public. Otherwise we could end up with services that look great on paper but...
We aim to make screening accessible and inclusive for all eligible populations. For people who are trans (transgender) or non-binary (any gender that is not exclusively male or female), inequalities may exist because...
June 2017 was a month to remember for a variety of reasons. All government publications were put on hold during the election period, so the PHE Screening blog team was silenced for a while.
The Level 3 Diploma for Health Screeners is now a requirement for all non-clinical screening staff in the abdominal aortic aneurysm (AAA), diabetic eye (DES) and newborn hearing (NHSP) programmes.